---
search:
  boost: 3
---

# HIV

This is a subcategory of Infectious Disease Agents.

## Decision Trees

- [Antivirals - HIV- Agents with BvG - Efavirenz/Lamivudine/Tenofovir Disoproxil Fumarate, Selzentry, Maraviroc, Intelence, Etravirine, Emtricitabine](https://forms.office.com/Pages/ResponsePage.aspx?id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBUNzJYUlFMU1RCN0FaUDhCTFkzUFM0WVdHQSQlQCN0PWcu){ :target="_blank" rel="noopener"}

- [Antivirals - HIV- Non-Preferred (Age Restricted) - Lamivudine Sol, Nevirapine Sol](https://forms.office.com/Pages/ResponsePage.aspx?id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBUNU5TWTJXRFdINzdXUzZYMzhSVUNTSE9HQyQlQCN0PWcu){ :target="_blank" rel="noopener"}

- [Antivirals - HIV- Non-Preferred - Abacavir Susp, Abacavir/Lamivudine/Zidovudine, Aptivus, Didanosine, Edurant, Fosamprenavir, Fuzeon, Lamivudine Tab, Lamivudine/Zidovudine, Nevirapine IR, Nevirapine ER Tab, Norvir Powder, Norvir Sol, Stavudine, Stribild, Tybost, Viracept](https://forms.office.com/Pages/ResponsePage.aspx?id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBUOTQxMVRGMVBLTjQ3TEI3SEZSNElFTFhMMiQlQCN0PWcu){ :target="_blank" rel="noopener"}

- [Antivirals - HIV- Preferred (Age Restricted) - Isentress Chew Tab](https://forms.office.com/Pages/ResponsePage.aspx?id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBUNExRSUtaTkQ0NzJJS1kzRFkyVzNPUE5aWSQlQCN0PWcu){ :target="_blank" rel="noopener"}

- [Antivirals - HIV- Preferred (PA) - Rukobia ER](https://forms.office.com/Pages/ResponsePage.aspx?id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBUME5LS1ZPNjAySElZQlFMTDZMOE0zMEs2VSQlQCN0PWcu){ :target="_blank" rel="noopener"}

- [Antivirals - HIV- Preferred (PA) - Triumeq PD](https://forms.office.com/Pages/ResponsePage.aspx?id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBUM1ZOQ1RQR05WUkVRRjA4NU9SSlo1M0IxNiQlQCN0PWcu){ :target="_blank" rel="noopener"}

## Formulary

### Preferred

| Preferred                                     | Generic Name | Quantity | Time (Days) |
|:----------------------------------------------|:-------------|:--------:|:-----------:|
| Abacavir Sulfate                              |              |          |             |
| Abacavir / Lamivudine                         |              |          |             |
| Apretude                                      |              |          |             |
| Atazanavir Sulfate                            |              |          |             |
| Biktarvy                                      |              |          |             |
| Cimduo                                        |              |          |             |
| Complera                                      |              |          |             |
| Delstrigo                                     |              |          |             |
| Descovy                                       |              |          |             |
| Dovato                                        |              |          |             |
| Efavirenz                                     |              |          |             |
| Efavirenz / Emtricitabine / Tenofovir         |              |          |             |
| Emtricitabine / Tenofovir Disoproxil Fumarate |              |          |             |
| Emtriva <sup>BvG  ==(Process by NDC)==</sup>                        |              |          |             |
| Evotaz                                        |              |          |             |
| Genvoya                                       |              |          |             |
| Isentress Chew Tab <sup>AR</sup>              |              |          |             |
| Isentress                                     |              |          |             |
| Juluca                                        |              |          |             |
| Lopinavir / Ritonavir                         |              |          |             |
| Odefsey                                       |              |          |             |
| Pifeltro                                      |              |          |             |
| Prezcobix                                     |              |          |             |
| Prezista <sup>BVG (==Process by NDC==- Weekly Updates)</sup>       |              |          |             |
| Ritonavir Tab                                 |              |          |             |
| Rukobia ER <sup>PA</sup>                      |              |          |             |
| Symfi <sup>BvG ==(Process by NDC)==</sup>                          |              |          |             |
| Symfi Lo <sup>BvG ==(Process by NDC)==</sup>                       |              |          |             |
| Symtuza                                       |              |          |             |
| Temixys                                       |              |          |             |
| Tenofovir Disoproxil Fumarate 300 MG          |              |          |             |
| Tivicay                                       |              |          |             |
| Tivicay PD                                    |              |          |             |
| Triumeq                                       |              |          |             |
| Triumeq PD <sup>PA</sup>                      |              |          |             |
| Viread Tab                                    |              |          |             |
| Viread Powder                                 |              |          |             |
| Zidovudine                                    |              |          |             |

### Non-Preferred

| Non-Preferred                                                                                                                              | Generic Name | Quantity | Time (Days) |
|:-------------------------------------------------------------------------------------------------------------------------------------------|:-------------|:--------:|:-----------:|
| Abacavir Susp                                                                                                                              |              |          |             |
| Abacavir / Lamivudine / Zidovudine                                                                                                         |              |          |             |
| Aptivus                                                                                                                                    |              |          |             |
| Didanosine                                                                                                                                 |              |          |             |
| Edurant                                                                                                                                    |              |          |             |
| <span title = "Brands Preferred: Symfi, Symfi Lo">Efavirenz / Lamivudine / Tenofovir Disoproxil Fumarate</span> <sup>Brand Preferred</sup> |              |          |             |
| <span title = "Brand Preferred: Emtriva">Emtricitabine</span> <sup>Brand Preferred</sup>                                                   |              |          |             |
| Fosamprenavir                                                                                                                              |              |          |             |
| Fuzeon                                                                                                                                     |              |          |             |
| Intelence <sup>BvG ==(Process by NDC)==</sup>                                                                                                                   |              |          |             |
| Lamivudine Tab                                                                                                                             |              |          |             |
| Lamivudine Sol <sup>AR</sup>                                                                                                               |              |          |             |
| Lamivudine / Zidovudine                                                                                                                    |              |          |             |
| Nevirapine IR, ER Tab                                                                                                                      |              |          |             |
| Nevirapine Sol <sup>AR</sup>                                                                                                               |              |          |             |
| Norvir Powder, Sol                                                                                                                         |              |          |             |
| Selzentry <sup>BvG ==(Process by NDC)==</sup>                                                                                                                   |              |          |             |
| Stavudine                                                                                                                                  |              |          |             |
| Stribild                                                                                                                                   |              |          |             |
| Tybost                                                                                                                                     |              |          |             |
| Viracept                                                                                                                                   |              |          |             |

## Authorizations

**Length of Authorizations**: 365 Days

### Grandfathering*

Patients who have a claim for a non-preferred drug in the previous 120 days will be automatically approved to continue the drug. Patients who have taken the drug previously, but do not have claims history (e.g. new to Medicaid), will need to submit a prior authorization in order to continue coverage.

**All Authorizations**: Must be prescribed in accordance with FDA approved labeling

## Criteria

### Abacavir/Dolutegravir/Lamivudine

Abacavir/Dolutegravir/Lamivudine (Triumeq PD) Criteria

-   Must provide documentation of patient’s weight (only authorized for those 10 – 25 kg)

### Non-Preferred

Non-Preferred Criteria

-   Must provide documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances) **OR**
    -   For any nonsolid oral dosage formulation: must provide documentation of medical necessity for why patient cannot be changed to a solid oral dosage formulation
-   Must have had an inadequate clinical response of at least **30 days** with at least **one preferred** drug. If applicable, the request must address the inability to use the individual components.
    -   For non-preferred extended-release formulations: must provide documentation of an inadequate clinical response with its immediate release formulation (if available)
    -   For non-preferred brand names that have preferred generics: must provide documentation of an inadequate clinical response or allergy to two or more generic labelers (if available)
 
[***HIV PRe-Exposure Prophylaxis (PREP) Medications](https://special-spoon-f542dccd.pages.github.io/Pharmacist%20Reference%20Guide/Clinical%20and%20PA%20Notes/hivprep/?h=desco)

### Subsequent Authorization

Subsequent Authorization Criteria

-   Must provide information of patient’s clinical response to treatment and ongoing safety monitoring

**AR** – Isentress chewable tablet: a PA is required for patients 12 years and older

**AR** – Lamivudine solution: a PA is required for patients 3 years and older

**AR** – Nevirapine solution: a PA is required for patients 3 years and older

## Links

[Denial Language (Rph Use Only: Technicians CANNOT deny Prior Authorizations)](https://mygainwell-my.sharepoint.com.mcas.ms/:w:/r/personal/rachel_carpenter_gainwelltechnologies_com/_layouts/15/Doc.aspx?sourcedoc=%7BCD777F63-7F18-4713-8D6A-B043BEE631F5%7D&file=Denial%20Language%20Updated%2009112023.docx&action=embedview&mobileredirect=true&wdStartOn=79&cid=f4472ece-6d4f-4694-b0c5-c150a2f53fea){:target="_blank" rel="noopener"}

[Criteria](https://medicaid.ohio.gov/static/PHM/drug-coverage/20231001+UPDL+Criteria+_v2.FINAL.pdf#page=86){:target="_blank" rel="noopener"}

[Preferred Drug List](https://medicaid.ohio.gov/static/PHM/drug-coverage/20231001_UPDL_V2.FINAL.hyperlinks_added.pdf#page=28){:target="_blank" rel="noopener"}

[Quantity Limit List](https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/Quantity%20Limits.pdf){:target="_blank" rel="noopener"}
